ENTITY

AptaBio Therapeutics (293780 KS)

20

Analysis

Health Care • South Korea

Aptabio Therapeutics Inc. operates pharmaceutical production businesses. The Company produces anticancer drugs and other pharmaceutical products. Aptabio Therapeutics conducts businesses in Korea.

more

Refresh

Exchange Announcement • 23 Dec 2024 10:44

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX-343Aì ì 1ì ìììíê³í ì¹ì¸ì ì²(IND))

Exchange Announcement • 11 Dec 2024 11:09

Material Management Information related to Judgment of Investment(IND Approval Determination)((APX115(Isuzinaxib)ì ì 2bì ìììíê³í(IND) ì¹ì¸))

Exchange Announcement • 10 Sep 2024 14:39

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX115(Isuzinaxib)ì ì 2bì ìììíê³í ì¹ì¸ì ì²(IND))

Exchange Announcement • 28 Aug 2024 15:39

Other Management Information(Voluntary Disclosure)(ì íì°ì ì£¼ì ë³´íµì£¼ ì íì²êµ¬)

Exchange Announcement • 23 Jul 2024 11:15

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x